Plasma DYRK1A as a novel risk factor for Alzheimer's disease

To determine whether apparent involvement of DYRK1A in Alzheimer's disease (AD) pathology makes it a candidate plasma biomarker for diagnosis, we developed a method to quantify plasma DYRK1A by immunoblot in transgenic mouse models having different gene dosages of Dyrk1a, and, consequently, dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Janel, N, Sarazin, M, Corlier, F, Corne, H, de Souza, L C, Hamelin, L, Aka, A, Lagarde, J, Blehaut, H, Hindié, V, Rain, J-C, Arbones, M L, Dubois, B, Potier, M C, Bottlaender, M, Delabar, J M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150238/
https://www.ncbi.nlm.nih.gov/pubmed/25116835
http://dx.doi.org/10.1038/tp.2014.61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150238/
https://www.ncbi.nlm.nih.gov/pubmed/25116835
http://dx.doi.org/10.1038/tp.2014.61

Ejemplares similares